Krystal Villalobos-Ayala

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Tomar Ghansah · 2 shared papers, 2020–2022 · strength 0.25
   • Paper Apigenin Targets MicroRNA-155, Enhances SHIP-1 Expression, and Augments Anti-Tumor Responses in Pancreatic Cancer. DOI 10.3390/cancers14153613↗
   • Paper Apigenin Increases SHIP-1 Expression, Promotes Tumoricidal Macrophages and Anti-Tumor Immune Responses in Murine Pancre… DOI 10.3390/cancers12123631↗
2. Kazim M. Husain · 2 shared papers, 2020–2022 · strength 0.25
   • Paper Apigenin Targets MicroRNA-155, Enhances SHIP-1 Expression, and Augments Anti-Tumor Responses in Pancreatic Cancer. DOI 10.3390/cancers14153613↗
   • Paper Apigenin Increases SHIP-1 Expression, Promotes Tumoricidal Macrophages and Anti-Tumor Immune Responses in Murine Pancre… DOI 10.3390/cancers12123631↗
3. Palanisamy Nallasamy · 1 shared paper, 2026 · strength 0.24
   • Paper Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. DOI 10.1053/j.gastro.2026.04.041↗
4. Pranita Atri · 1 shared paper, 2026 · strength 0.24
   • Paper Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. DOI 10.1053/j.gastro.2026.04.041↗
5. Jesse L. Cox · 1 shared paper, 2026 · strength 0.24
   • Paper Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. DOI 10.1053/j.gastro.2026.04.041↗
6. Imran Khan · 1 shared paper, 2026 · strength 0.24
   • Paper Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. DOI 10.1053/j.gastro.2026.04.041↗
7. Namita Bhyravbhatla · 1 shared paper, 2026 · strength 0.24
   • Paper Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. DOI 10.1053/j.gastro.2026.04.041↗
8. Saravanakumar Marimuthu · 1 shared paper, 2026 · strength 0.24
   • Paper Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. DOI 10.1053/j.gastro.2026.04.041↗
9. Zahraa Wajih Alsafwani · 1 shared paper, 2026 · strength 0.24
   • Paper Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. DOI 10.1053/j.gastro.2026.04.041↗
10. Margaret A. Park · 1 shared paper, 2026 · strength 0.24
    • Paper Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. DOI 10.1053/j.gastro.2026.04.041↗
11. Barbara Ann Centeno · 1 shared paper, 2026 · strength 0.24
    • Paper Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. DOI 10.1053/j.gastro.2026.04.041↗
12. Mokenge Peter Malafa · 1 shared paper, 2026 · strength 0.24
    • Paper Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. DOI 10.1053/j.gastro.2026.04.041↗
13. Surinder K. Batra · 1 shared paper, 2026 · strength 0.24
    • Paper Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. DOI 10.1053/j.gastro.2026.04.041↗
14. Sushil Kumar · 1 shared paper, 2026 · strength 0.24
    • Paper Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. DOI 10.1053/j.gastro.2026.04.041↗
15. Clayton Clopton Yates · 1 shared paper, 2022 · strength 0.14
    • Paper Apigenin Targets MicroRNA-155, Enhances SHIP-1 Expression, and Augments Anti-Tumor Responses in Pancreatic Cancer. DOI 10.3390/cancers14153613↗
16. George Blanck · 1 shared paper, 2022 · strength 0.14
    • Paper Apigenin Targets MicroRNA-155, Enhances SHIP-1 Expression, and Augments Anti-Tumor Responses in Pancreatic Cancer. DOI 10.3390/cancers14153613↗
17. Kun Jiang · 1 shared paper, 2020 · strength 0.11
    • Paper Apigenin Increases SHIP-1 Expression, Promotes Tumoricidal Macrophages and Anti-Tumor Immune Responses in Murine Pancre… DOI 10.3390/cancers12123631↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.